Your browser doesn't support javascript.
loading
Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Krämer, A; Bochtler, T; Pauli, C; Baciarello, G; Delorme, S; Hemminki, K; Mileshkin, L; Moch, H; Oien, K; Olivier, T; Patrikidou, A; Wasan, H; Zarkavelis, G; Pentheroudakis, G; Fizazi, K.
Afiliação
  • Krämer A; Clinical Cooperation Unit Molecular Haematology/Oncology, German Cancer Research Center (DKFZ) Heidelberg, Germany; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Bochtler T; Clinical Cooperation Unit Molecular Haematology/Oncology, German Cancer Research Center (DKFZ) Heidelberg, Germany; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, He
  • Pauli C; Department of Pathology and Molecular Pathology, University Hospital Zurich (USZ), Zurich, Switzerland; Medical Faculty, University of Zurich (UZH), Zurich, Switzerland.
  • Baciarello G; Medical Oncology Department, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.
  • Delorme S; Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg.
  • Hemminki K; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and Biomedical Center, Charles University, Pilsen, Czech Republic.
  • Mileshkin L; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich (USZ), Zurich, Switzerland; Medical Faculty, University of Zurich (UZH), Zurich, Switzerland.
  • Oien K; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Olivier T; Department of Oncology, Geneva University Hospital, Geneva, Switzerland; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, USA.
  • Patrikidou A; Department of Cancer Medicine, Institute Gustave Roussy, University of Paris Saclay, Villejuif, France.
  • Wasan H; Department of Cancer Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Zarkavelis G; Department of Medical Oncology, University of Ioannina, Ioannina, Greece.
  • Pentheroudakis G; European Society for Medical Oncology, Lugano, Switzerland.
  • Fizazi K; Department of Cancer Medicine, Institute Gustave Roussy, University of Paris Saclay, Villejuif, France.
Ann Oncol ; 34(3): 228-246, 2023 03.
Article em En | MEDLINE | ID: mdl-36563965
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Primárias Desconhecidas Tipo de estudo: Diagnostic_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Primárias Desconhecidas Tipo de estudo: Diagnostic_studies / Guideline / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article